Table 2.
Multivariable proportional hazard Cox models for overall survival.
Parameter | Value | Univariate p | Multivariable p | Multivariable HR | HR 95% Confidence Limits |
---|---|---|---|---|---|
Liver curative surgery | No | <0.0001 | <0.0001 | 1.77 | 1.43; 2.17 |
Concomitant extrahepatic disease | Yes | 0.003 | 0.0442 | 1.27 | 1.01; 1.61 |
Isolated liver metastasis | No | <0.0001 | 0.0022 | 1.44 | 1.14; 1.82 |
Nodal involvement of primary | Yes | <0.0001 | 0.0051 | 1.28 | 1.08; 1.53 |
First-line PO-SACT | No | 0.0008 | 0.0003 | 1.50 | 1.21; 1.87 |
Use of anti-EGFR mAb | No | 0.081 | 0.0491 | 1.24 | 1.00; 1.55 |
PO-SACT duration | Long | 0.001 | 0.0460 | 1.18 | 1.00; 1.39 |
EGFR: epithelial growth factor receptor; HR: hazard ratio; mAb: monoclonal antibody; PO-SACT: pre-operative systemic anticancer therapy.